ctrl K

Watchlist Price Alert

Nurix Therapeutics Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

9.59

-0.14 (-1.44%)

At close: May 14, 2025, 3:59 PM

9.71

1.25%

After-hours: May 14, 2025, 07:59 PM EDT

Nurix Therapeutics Revenue Breakdown

Period Ending	Nov 30, 2024	Nov 30, 2023
Collaboration Revenue Revenue	54.55M	56.99M
Collaboration Revenue Revenue Growth	-4.28%	n/a

Operating Expense Breakdown

Period Ending	Feb 28, 2025	Nov 30, 2024	Aug 31, 2024	May 31, 2024	Feb 29, 2024	Nov 30, 2023	Aug 31, 2023	May 31, 2023	Feb 28, 2023	Nov 30, 2022	Aug 31, 2022	May 31, 2022	Feb 28, 2022	Nov 30, 2021	Aug 31, 2021	May 31, 2021	Feb 28, 2021	Nov 30, 2020	Aug 31, 2020	May 31, 2020	Feb 29, 2020	Nov 30, 2019	Aug 31, 2019	May 31, 2019	Feb 28, 2019
Selling, General, and Administrative Revenue	11.65M	10.72M	11.72M	9.95M	9.96M	8.96M	10.62M	11.68M	9.82M	9.37M	9.75M	9.65M	9.23M	8.82M	8.34M	7.51M	6.53M	6.25M	4.34M	3.27M	2.45M	2.6M	2.18M	1.87M	1.67M
Selling, General, and Administrative Revenue Growth	+8.74%	-8.54%	+17.78%	-0.07%	+11.15%	-15.68%	-9.03%	+18.91%	+4.85%	-3.91%	+0.97%	+4.62%	+4.65%	+5.69%	+11.08%	+15.02%	+4.45%	+44.12%	+32.66%	+33.47%	-5.84%	+19.14%	+16.79%	+11.98%	n/a
Research and Development Revenue	69.66M	67.22M	55.48M	46.59M	47.96M	47.78M	47.86M	45.76M	45.82M	46.11M	47.76M	47.49M	43.14M	36.53M	30.91M	25.99M	23M	20.45M	18.94M	14.14M	12.97M	12.82M	11.01M	10.76M	10.43M
Research and Development Revenue Growth	+3.63%	+21.17%	+19.08%	-2.85%	+0.38%	-0.16%	+4.57%	-0.12%	-0.63%	-3.47%	+0.56%	+10.10%	+18.08%	+18.20%	+18.90%	+13.00%	+12.51%	+7.95%	+33.92%	+9.06%	+1.12%	+16.50%	+2.31%	+3.11%	n/a